Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T14:52:03.484Z.
Calculation as of: 2026-10-06T14:52:03.484Z.
Quote observation: 2026-10-06T14:49:26.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
PE RATIO
N/A
Market Cap
$37.09M
PE Ratio
11.22
TTM Avg
85.66
3Y Avg
71.67
5Y Avg
45.10
Market Cap
$39.23M
PE Ratio
181.67
TTM Avg
166.68
3Y Avg
110.06
5Y Avg
110.06
Market Cap
$25.90M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$25.50M
PE Ratio
5.52
TTM Avg
11.87
3Y Avg
21.43
5Y Avg
21.63
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| FG Communities Holdings Inc. (FGC) | $32.62M | N/A | N/A | N/A | N/A |
| BayFirst Financial Corp. (BAFN)vs › | $31.54M | N/A | 11.22 | 72.99 | 45.20 |
| Fold Holdings, Inc. (FLD)vs › | $29.90M | N/A | 113.71 | 113.71 | 113.71 |
| Mount Logan Capital Inc. (MLCI)vs › | $36.60M | N/A | N/A | N/A | N/A |
| U.S. Global Investors, Inc. (GROW)vs › | $37.09M | 11.22 | 85.66 | 71.67 | 45.10 |
| Aimei Health Technology Co., Ltd (AFJK)vs › | $39.23M | 181.67 | 166.68 | 110.06 | 110.06 |
| Grande Group Limited Class A Ordinary Shares (GRAN)vs › | $25.90M | N/A | N/A | N/A | N/A |
| Kestrel Group Ltd (KG)vs › | $39.35M | N/A | 1.18 | 1.18 | 1.18 |
| Atlantic American Corporation (AAME)vs › | $25.50M | 5.52 | 11.87 | 21.43 | 21.63 |
| A SPAC III Acquisition Corp. (ASPC)vs › | $25.22M | 459.15 | 155.22 | 219.61 | 219.61 |
Trailing P/E
N/A
Forward P/E
N/A
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
